1,721,138 research outputs found
sj-docx-1-tau-10.1177_17562872211053189 – Supplemental material for Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis
No full textSupplemental material, sj-docx-1-tau-10.1177_17562872211053189 for Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis by Carlo Cattrini, Carlo Messina, Chiara Airoldi, Sebastiano Buti, Giandomenico Roviello, Alessia Mennitto, Orazio Caffo, Alessandra Gennari and Melissa Bersanelli in Therapeutic Advances in Urology</p
sj-docx-1-onc-10.1177_11795549211043427 – Supplemental material for Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study
No full textSupplemental material, sj-docx-1-onc-10.1177_11795549211043427 for Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study by Sebastiano Buti, Fabiana Perrone, Teresa Zielli, Giulia Mazzaschi, Chiara Casartelli, Alessandro Leonetti, Gianluca Milanese, Mario Silva, Roberta Eufrasia Ledda, Antonino Musolino, Francesca Pucci, Melissa Bersanelli and Marcello Tiseo in Clinical Medicine Insights: Oncology</p
sj-jpg-1-onc-10.1177_11795549211043427 – Supplemental material for Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study
No full textSupplemental material, sj-jpg-1-onc-10.1177_11795549211043427 for Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study by Sebastiano Buti, Fabiana Perrone, Teresa Zielli, Giulia Mazzaschi, Chiara Casartelli, Alessandro Leonetti, Gianluca Milanese, Mario Silva, Roberta Eufrasia Ledda, Antonino Musolino, Francesca Pucci, Melissa Bersanelli and Marcello Tiseo in Clinical Medicine Insights: Oncology</p
sj-doc-1-tct-10.1177_15330338231159753 - Supplemental material for Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario
No full textSupplemental material, sj-doc-1-tct-10.1177_15330338231159753 for Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical Challenge in the Current Therapeutic Scenario by Giulia Mazzaschi, Giulia Claire Giudice, Matilde Corianò, Davide Campobasso, Fabiana Perrone, Michele Maffezzoli, Irene Testi, Luca Isella, Umberto Maestroni and Sebastiano Buti in Technology in Cancer Research & Treatment</p
sj-pdf-1-tmj-10.1177_03008916211047888 – Supplemental material for Transient asymptomatic pulmonary opacities and interstitial lung disease in EGFR-mutated non-small cell lung cancer treated with osimertinib
No full textSupplemental material, sj-pdf-1-tmj-10.1177_03008916211047888 for Transient asymptomatic pulmonary opacities and interstitial lung disease in EGFR-mutated non-small cell lung cancer treated with osimertinib by Gianluca Taronna, Alessandro Leonetti, Filippo Gustavo Dall’Olio, Alessandro Rizzo, Claudia Parisi, Sebastiano Buti, Paola Bordi, Stefano Brocchi, Rita Golfieri, Andrea Ardizzoni, Nicola Sverzellati and Marcello Tiseo in Tumori Journal</p
sj-pdf-2-tmj-10.1177_03008916211047888 – Supplemental material for Transient asymptomatic pulmonary opacities and interstitial lung disease in EGFR-mutated non-small cell lung cancer treated with osimertinib
No full textSupplemental material, sj-pdf-2-tmj-10.1177_03008916211047888 for Transient asymptomatic pulmonary opacities and interstitial lung disease in EGFR-mutated non-small cell lung cancer treated with osimertinib by Gianluca Taronna, Alessandro Leonetti, Filippo Gustavo Dall’Olio, Alessandro Rizzo, Claudia Parisi, Sebastiano Buti, Paola Bordi, Stefano Brocchi, Rita Golfieri, Andrea Ardizzoni, Nicola Sverzellati and Marcello Tiseo in Tumori Journal</p
sj-docx-1-tau-10.1177_17562872231187216 – Supplemental material for The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study
No full textSupplemental material, sj-docx-1-tau-10.1177_17562872231187216 for The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study by Chiara Tommasi, Giulia Scartabellati, Diana Giannarelli, Ugo De Giorgi, Nicole Brighi, Giuseppe Fornarini, Sara Elena Rebuzzi, Silvia Puglisi, Orazio Caffo, Stefania Kinspergher, Alessia Mennitto, Carlo Cattrini, Matteo Santoni, Elena Verzoni, Alessandro Rametta, Marco Stellato, Andrea Malgeri, Giandomenico Roviello, Matteo Brunelli and Sebastiano Buti in Therapeutic Advances in Urology</p
sj-pptx-2-tau-10.1177_17562872231187216 – Supplemental material for The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study
No full textSupplemental material, sj-pptx-2-tau-10.1177_17562872231187216 for The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study by Chiara Tommasi, Giulia Scartabellati, Diana Giannarelli, Ugo De Giorgi, Nicole Brighi, Giuseppe Fornarini, Sara Elena Rebuzzi, Silvia Puglisi, Orazio Caffo, Stefania Kinspergher, Alessia Mennitto, Carlo Cattrini, Matteo Santoni, Elena Verzoni, Alessandro Rametta, Marco Stellato, Andrea Malgeri, Giandomenico Roviello, Matteo Brunelli and Sebastiano Buti in Therapeutic Advances in Urology</p
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
- …
